Moleculin Biotech, Inc. (MBRX)
Nasdaq: MBRX · Pharmaceutical Preparations · Houston, TX · filing with the SEC since 2015
Who runs Moleculin Biotech, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Klemp Walter V
CEO and President. First filing Jun 2016, latest Nov 6, 2026, 8 filings in all.
Officers reporting now
3
of 8 people with a filing in the last fifteen months
Directors reporting now
5
10 people on the record since 2016
Officerssales are open-market, Nov 6, 2025 to Nov 6, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Klemp Walter V | CEO and President | Jun 2016 | Nov 6, 2026 | none |
| Foster Jonathan P. | Chief Financial Officer | Aug 2016 | Nov 6, 2026 | none |
| Picker Donald H | Chief Science Officer | Aug 2016 | Nov 6, 2026 | none |
Directorssales are open-market, Nov 6, 2025 to Nov 6, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Cannon Michael D | director | Jun 2016 | Nov 14, 2025 | none |
| Cermak Elizabeth | director | Oct 2020 | Nov 14, 2025 | none |
| Climaco John M | director | Jul 2017 | Nov 14, 2025 | none |
| George Robert E. | director | Jun 2016 | Nov 14, 2025 | none |
| Yan Joy | director | Mar 2022 | Nov 14, 2025 | none |
Earlier names on the record3, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.